UK markets closed
  • NIKKEI 225

    27,685.47
    -8.18 (-0.03%)
     
  • HANG SENG

    21,298.70
    +76.54 (+0.36%)
     
  • CRUDE OIL

    77.28
    +3.17 (+4.28%)
     
  • GOLD FUTURES

    1,881.30
    +1.80 (+0.10%)
     
  • DOW

    34,084.99
    +193.97 (+0.57%)
     
  • BTC-GBP

    19,274.40
    +79.75 (+0.42%)
     
  • CMC Crypto 200

    533.96
    +8.01 (+1.52%)
     
  • ^IXIC

    12,081.84
    +194.39 (+1.64%)
     
  • ^FTAS

    4,309.87
    +5.97 (+0.14%)
     

Global Local Anesthesia Drugs Market to Reach $3.6 Billion by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Local Anesthesia Drugs estimated at US$2. 6 Billion in the year 2020, is projected to reach a revised size of US$3. 6 Billion by 2027, growing at a CAGR of 4.

New York, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Local Anesthesia Drugs Industry" - https://www.reportlinker.com/p06032076/?utm_source=GNW
7% over the analysis period 2020-2027. Lidocaine, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Bupivacaine segment is readjusted to a revised 5.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $718.8 Million, While China is Forecast to Grow at 7.7% CAGR

The Local Anesthesia Drugs market in the U.S. is estimated at US$718.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$745.3 Million by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$484.4 Million by the year 2027.



Ropivacaine Segment to Record 5.1% CAGR

In the global Ropivacaine segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$278.1 Million in the year 2020 will reach a projected size of US$386 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.5% CAGR through the analysis period.

Select Competitors (Total 43 Featured) -
Aspen Pharmacare
Fresenius SE & Co. KGaA
Mylan
Pacira Pharmaceuticals, Inc.
Pfizer Inc.
Pierrel group
Sagent Pharmaceutical, Inc.
Teva Pharmaceuticals


Read the full report: https://www.reportlinker.com/p06032076/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Local Anesthesia Drugs - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Local
Anesthesia Drugs by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Local Anesthesia Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Local Anesthesia Drugs
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Lidocaine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Lidocaine by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Lidocaine by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Bupivacaine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Bupivacaine by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Bupivacaine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Ropivacaine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Ropivacaine by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Ropivacaine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Prilocaine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Prilocaine by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Prilocaine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Other Product Segments by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Other Product Segments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Other Product Segments
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Injectable by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Injectable by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Injectable by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Surface Anesthetic by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Surface Anesthetic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Surface Anesthetic by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Local Anesthesia Drugs Market Analysis of
Annual Sales in US$ Million for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 26: USA Recent Past, Current & Future Analysis for Local
Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine,
Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 27: USA Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 28: USA 15-Year Perspective for Local Anesthesia Drugs by
Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 29: USA Recent Past, Current & Future Analysis for Local
Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 30: USA Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 31: USA 15-Year Perspective for Local Anesthesia Drugs by
Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

CANADA
Table 32: Canada Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 33: Canada Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 34: Canada 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 35: Canada Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 36: Canada Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 37: Canada 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

JAPAN
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 38: Japan Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 39: Japan Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 40: Japan 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 41: Japan Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 42: Japan Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 43: Japan 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

CHINA
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 44: China Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 45: China Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 46: China 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 47: China Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 48: China Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 49: China 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

EUROPE
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 50: Europe Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 51: Europe Historic Review for Local Anesthesia Drugs by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 52: Europe 15-Year Perspective for Local Anesthesia Drugs
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 53: Europe Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 54: Europe Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 55: Europe 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 56: Europe Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 57: Europe Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 58: Europe 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

FRANCE
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 59: France Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 60: France Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 61: France 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 62: France Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 63: France Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 64: France 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

GERMANY
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 65: Germany Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 66: Germany Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 67: Germany 15-Year Perspective for Local Anesthesia
Drugs by Product Segment - Percentage Breakdown of Value Sales
for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 68: Germany Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 69: Germany Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 70: Germany 15-Year Perspective for Local Anesthesia
Drugs by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

ITALY
Table 71: Italy Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 72: Italy Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 73: Italy 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 74: Italy Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 75: Italy Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 76: Italy 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

UNITED KINGDOM
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 77: UK Recent Past, Current & Future Analysis for Local
Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine,
Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 78: UK Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 79: UK 15-Year Perspective for Local Anesthesia Drugs by
Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 80: UK Recent Past, Current & Future Analysis for Local
Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 81: UK Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 82: UK 15-Year Perspective for Local Anesthesia Drugs by
Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

SPAIN
Table 83: Spain Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 84: Spain Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 85: Spain 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 86: Spain Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 87: Spain Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 88: Spain 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

RUSSIA
Table 89: Russia Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 90: Russia Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 91: Russia 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 92: Russia Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 93: Russia Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 94: Russia 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

REST OF EUROPE
Table 95: Rest of Europe Recent Past, Current & Future Analysis
for Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 96: Rest of Europe Historic Review for Local Anesthesia
Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 97: Rest of Europe 15-Year Perspective for Local
Anesthesia Drugs by Product Segment - Percentage Breakdown of
Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine
and Other Product Segments for the Years 2012, 2021 & 2027

Table 98: Rest of Europe Recent Past, Current & Future Analysis
for Local Anesthesia Drugs by Application - Injectable and
Surface Anesthetic - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 99: Rest of Europe Historic Review for Local Anesthesia
Drugs by Application - Injectable and Surface Anesthetic
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 100: Rest of Europe 15-Year Perspective for Local
Anesthesia Drugs by Application - Percentage Breakdown of Value
Sales for Injectable and Surface Anesthetic for the Years 2012,
2021 & 2027

ASIA-PACIFIC
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 101: Asia-Pacific Recent Past, Current & Future Analysis
for Local Anesthesia Drugs by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 102: Asia-Pacific Historic Review for Local Anesthesia
Drugs by Geographic Region - Australia, India, South Korea and
Rest of Asia-Pacific Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 103: Asia-Pacific 15-Year Perspective for Local
Anesthesia Drugs by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2021 & 2027

Table 104: Asia-Pacific Recent Past, Current & Future Analysis
for Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 105: Asia-Pacific Historic Review for Local Anesthesia
Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 106: Asia-Pacific 15-Year Perspective for Local
Anesthesia Drugs by Product Segment - Percentage Breakdown of
Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine
and Other Product Segments for the Years 2012, 2021 & 2027

Table 107: Asia-Pacific Recent Past, Current & Future Analysis
for Local Anesthesia Drugs by Application - Injectable and
Surface Anesthetic - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 108: Asia-Pacific Historic Review for Local Anesthesia
Drugs by Application - Injectable and Surface Anesthetic
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 109: Asia-Pacific 15-Year Perspective for Local
Anesthesia Drugs by Application - Percentage Breakdown of Value
Sales for Injectable and Surface Anesthetic for the Years 2012,
2021 & 2027

AUSTRALIA
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Australia for 2022 (E)
Table 110: Australia Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 111: Australia Historic Review for Local Anesthesia Drugs
by Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 112: Australia 15-Year Perspective for Local Anesthesia
Drugs by Product Segment - Percentage Breakdown of Value Sales
for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 113: Australia Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 114: Australia Historic Review for Local Anesthesia Drugs
by Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 115: Australia 15-Year Perspective for Local Anesthesia
Drugs by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

INDIA
Local Anesthesia Drugs Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in India for 2022 (E)
Table 116: India Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 117: India Historic Review for Local Anesthesia Drugs by
Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 118: India 15-Year Perspective for Local Anesthesia Drugs
by Product Segment - Percentage Breakdown of Value Sales for
Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 119: India Recent Past, Current & Future Analysis for
Local Anesthesia Drugs by Application - Injectable and Surface
Anesthetic - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 120: India Historic Review for Local Anesthesia Drugs by
Application - Injectable and Surface Anesthetic Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 121: India 15-Year Perspective for Local Anesthesia Drugs
by Application - Percentage Breakdown of Value Sales for
Injectable and Surface Anesthetic for the Years 2012, 2021 &
2027

SOUTH KOREA
Table 122: South Korea Recent Past, Current & Future Analysis
for Local Anesthesia Drugs by Product Segment - Lidocaine,
Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 123: South Korea Historic Review for Local Anesthesia
Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine,
Prilocaine and Other Product Segments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 124: South Korea 15-Year Perspective for Local Anesthesia
Drugs by Product Segment - Percentage Breakdown of Value Sales
for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other
Product Segments for the Years 2012, 2021 & 2027

Table 125: South Korea Recent Past, Current & Future Analysis
for Local Anesthesia Drugs by Application - Injectable and

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032076/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001